( July 22, 2026, 16:04 GMT | Official Statement) -- MLex Summary: Mosaic Health opposed a petition for the US Supreme Court to review its antitrust case accusing Sanofi-Aventis, Eli Lilly, Novo Nordisk and Astrazeneca Pharmaceuticals of conspiring to retract a long-standing discount for safety-net hospitals and clinics, arguing that damages are not barred under the rule of Illinois Brick. “Petitioners’ joint restraints directly prevented safety net providers from buying drugs for shipment to contract pharmacies by barring such shipments; they did not indirectly reduce those sales by charging higher prices. Intermediaries were not overcharged, did not absorb or pass on any overcharge, and do not claim any injury,” Mosaic said. See attached file. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.